2026-05-06 Fenix Outdoor completes acquisition of minority stake in Devold Today, Fenix Outdoor International AG completed the acquisition of the minority shareholding in Devold of Norway AS, announced on Monday 27 April 2026. From today Fenix Outdoor holds 100% of Devold. If any further questions, please contact: CFO of Fenix Outdoor, Thomas Lindberg, + 46 703 33 17 63AttachmentPress release 2026 05 06

WEST PALM BEACH, Fla. and CENTENNIAL, Colo., May 06, 2026 (GLOBE NEWSWIRE) — Siris (together with its affiliates, “Siris”), a leading private equity firm targeting services companies that support critical technology infrastructure, today announced the completion of its previously announced acquisition of a majority stake in TAKKION, a premier integrated services provider to the renewable energy industry, from funds managed by Apollo (NYSE:APO) (the “Apollo Funds”). Through this partnership, Siris and TAKKION will look to further optimize the company’s operations, expand its proven service capabilities into adjacent renewable sectors, and pursue both organic and inorganic growth opportunities to drive long-term value creation. “The closing of this transaction is an important milestone for TAKKION as we look to capitalize on the increasing...

Transaction adds profitable revenue, proprietary technology, and expanded scale to capture a greater share of the under-monetized gaming advertising market SANTA MONICA, Calif., May 06, 2026 (GLOBE NEWSWIRE) — Super League (Nasdaq: SLE) (the “Company”), an audience intelligence and media activation company trusted by global brands to reach and engage people who play video games across the digital advertising landscape, today announced the closing of its previously announced acquisition of the Misfits Ads Division from Misfits Gaming Group. The transaction marks a meaningful step forward in Super League’s evolution, adding profitable revenue, improving the predictability of performance, expanding brand relationships, and reinforcing the Company’s path to cash-based EBITDA profitability. Super League Chief Executive Officer Matt Edelman...

Parties Extend Exclusivity Through June 30, 2026, Reaffirming Commitment to Proposed Transaction SINGAPORE, May 06, 2026 (GLOBE NEWSWIRE) — Currenc Group Inc. (Nasdaq: CURR) (“Currenc” or the “Company”), a fintech pioneer empowering financial institutions worldwide with artificial intelligence (“AI”) solutions, today announced that it has entered into an Amendment Deed with Animoca Brands Corporation Limited (ACN: 122 921 813) (“Animoca Brands”) and the Company’s Chairman and Chief Executive Officer, Alexander King Ong Kong, extending the exclusivity period under the previously disclosed term sheet for their proposed reverse merger (the “Proposed Transaction”) from three months from the original execution date to June 30, 2026. Transaction Background On November 2, 2025, Currenc and...

MONTREAL, May 06, 2026 (GLOBE NEWSWIRE) — Cannara Biotech Inc. (“Cannara”, the “Company”, “us” or “we”) (TSX: LOVE) (OTCQX: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at affordable prices, with two mega facilities based in Québec spanning over 1,600,000 sq. ft., today announced the closing of a transaction to acquire all of the shares of Medican Organic Inc. (“Medican”), a wholly owned subsidiary of BZAM Ltd., for an aggregate purchase price of $2.8 million. This acquisition completes Cannara’s prior acquisition of its Valleyfield cultivation and manufacturing facility, purchased from Medican on June 8, 2021. The acquisition was completed following Medican’s exit from proceedings under the Companies’ Creditors Arrangement Act (“CCAA”) involving Medican’s parent company. Since the initial...

Transaction marks one of the first clinical-stage oncology acquisitions sourced, evaluated, and executed through an AI-powered drug development platform NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) — Pathos AI, a clinical-stage AI and technology company advancing its own pipeline of cancer therapies, today announced the acquisition of a majority stake in DeuterOncology, a Belgium-based company developing DO-2, a third-generation MET kinase inhibitor for patients with MET-altered cancers. The asset was systematically identified, evaluated, and advanced to acquisition through the Pathos Foundry platform. Identified by Foundry As part of its core operations, Pathos utilizes Foundry to continuously analyze large-scale clinical and scientific datasets, including conference proceedings, regulatory filings, published trial data, and proprietary...

TORONTO, May 06, 2026 (GLOBE NEWSWIRE) — Firm Capital Property Trust (“FCPT” or the “Trust“) (TSX: FCD.UN) is pleased to announce the closing of the previously announced acquisition of a 50% interest in a 103 site Manufactured Home Community (“MHC”) located in Didsbury, Alberta for $8.5 million (100% ownership) excluding transaction costs. The Trust closed on this acquisition through its existing joint venture arrangement with SunPark Communities, LP (“SunPark”), such that the Trust owns 50% of this MHC and SunPark the remaining 50%. This acquisition strengthens the Trust’s growing MHC platform, a sector characterized by stable occupancies and consistent cash flows. The acquisition aligns with the Trust’s consistent focus on capital preservation and disciplined investing while expanding its presence in Western...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ANIMALCARE GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

HOUSTON, May 05, 2026 (GLOBE NEWSWIRE) — Plains All American Pipeline, L.P. (Nasdaq: PAA) and Plains GP Holdings (Nasdaq: PAGP) (collectively, “Plains”) today provided an update on the expected timing for completion of the Canadian NGL business divestiture to Keyera Corp (“Keyera”). PAA and certain of its affiliates have received a filing from the Canadian Competition Bureau challenging the proposed transaction. This filing and the associated proceeding do not enjoin, prohibit, make illegal or otherwise prevent the parties from closing the transaction, and Keyera and PAA intend to close the transaction in May 2026. Completion of the NGL divestiture will transform Plains to a pure play crude oil midstream company with integrated assets spanning from Canada to the U.S. Gulf Coast. Forward-Looking Statements Except for the historical...